| Primary |
| Attention Deficit/hyperactivity Disorder |
71.7% |
| Product Used For Unknown Indication |
13.1% |
| Drug Use For Unknown Indication |
5.5% |
| Depression |
2.4% |
| Anxiety |
1.0% |
| Disturbance In Attention |
0.9% |
| Asthma |
0.7% |
| Bipolar Disorder |
0.6% |
| Insomnia |
0.5% |
| Oppositional Defiant Disorder |
0.5% |
| Affective Disorder |
0.5% |
| Sleep Disorder |
0.5% |
| Hypersensitivity |
0.3% |
| Obsessive-compulsive Disorder |
0.3% |
| Hypertension |
0.3% |
| Convulsion |
0.2% |
| Migraine |
0.2% |
| Seasonal Allergy |
0.2% |
| Adhd |
0.2% |
| Aggression |
0.2% |
|
| Off Label Use |
15.4% |
| Weight Decreased |
9.2% |
| Suicidal Ideation |
8.2% |
| Tic |
7.5% |
| Drug Ineffective |
6.9% |
| Vomiting |
5.8% |
| Insomnia |
5.4% |
| Overdose |
4.3% |
| Drug Effect Decreased |
3.9% |
| Tremor |
3.9% |
| Somnolence |
3.7% |
| Psychomotor Hyperactivity |
3.6% |
| Vision Blurred |
3.6% |
| Syncope |
3.1% |
| Wrong Technique In Drug Usage Process |
2.8% |
| Irritability |
2.7% |
| Nausea |
2.7% |
| Product Quality Issue |
2.7% |
| Headache |
2.4% |
| Rash |
2.2% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
43.1% |
| Product Used For Unknown Indication |
20.9% |
| Depression |
7.7% |
| Affective Disorder |
6.2% |
| Anxiety |
3.9% |
| Sleep Disorder |
2.0% |
| Aggression |
1.8% |
| Insomnia |
1.8% |
| Drug Use For Unknown Indication |
1.7% |
| Bipolar Disorder |
1.6% |
| Asthma |
1.4% |
| Obsessive-compulsive Disorder |
1.4% |
| Oppositional Defiant Disorder |
1.1% |
| Mood Swings |
1.0% |
| Major Depression |
0.9% |
| Bipolar Ii Disorder |
0.8% |
| Hypertension |
0.8% |
| Disturbance In Attention |
0.7% |
| Impulsive Behaviour |
0.7% |
| Post-traumatic Stress Disorder |
0.7% |
|
| Weight Decreased |
11.7% |
| Suicidal Ideation |
11.2% |
| Wrong Technique In Drug Usage Process |
8.2% |
| Overdose |
6.6% |
| Drug Ineffective |
6.1% |
| Incorrect Dose Administered |
4.6% |
| Mood Altered |
4.6% |
| Tachycardia |
4.6% |
| Tremor |
4.6% |
| Disturbance In Attention |
4.1% |
| Impulsive Behaviour |
4.1% |
| Tic |
4.1% |
| Headache |
3.6% |
| Syncope |
3.6% |
| Treatment Noncompliance |
3.6% |
| Educational Problem |
3.1% |
| Psychotic Disorder |
3.1% |
| Violence-related Symptom |
3.1% |
| Vomiting |
3.1% |
| Aggression |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.3% |
| Attention Deficit/hyperactivity Disorder |
19.1% |
| Depression |
8.6% |
| Bipolar Disorder |
6.5% |
| Anxiety |
4.7% |
| Pain |
4.2% |
| Crohn's Disease |
3.4% |
| Affective Disorder |
2.6% |
| Asthma |
2.6% |
| Rheumatoid Arthritis |
2.5% |
| Hypertension |
2.3% |
| Insomnia |
2.3% |
| Psoriatic Arthropathy |
2.3% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Drug Use For Unknown Indication |
1.8% |
| Contraception |
1.7% |
| Multiple Sclerosis |
1.7% |
| Psoriasis |
1.5% |
| Sleep Disorder |
1.5% |
| Prophylaxis |
1.3% |
|
| Weight Increased |
10.5% |
| Off Label Use |
8.6% |
| Drug Ineffective |
7.6% |
| Nausea |
7.6% |
| Vomiting |
7.1% |
| Pain |
5.7% |
| Product Quality Issue |
5.2% |
| Insomnia |
4.8% |
| Pruritus |
4.8% |
| Rash |
4.8% |
| Viral Pharyngitis |
4.8% |
| Injection Site Pain |
4.3% |
| Tardive Dyskinesia |
3.3% |
| Tinnitus |
3.3% |
| Vision Blurred |
3.3% |
| Myalgia |
2.9% |
| Somnolence |
2.9% |
| Suicidal Ideation |
2.9% |
| Weight Decreased |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
|
| Interacting |
| Attention Deficit/hyperactivity Disorder |
28.6% |
| Depression |
21.4% |
| Onychomycosis |
21.4% |
| Drug Use For Unknown Indication |
10.7% |
| Sleep Apnoea Syndrome |
7.1% |
| Bipolar Disorder |
3.6% |
| Erectile Dysfunction |
3.6% |
| Nasal Congestion |
3.6% |
|
| Tremor |
50.0% |
| Drug Interaction |
25.0% |
| Change In Sustained Attention |
8.3% |
| Off Label Use |
8.3% |
| Weight Increased |
8.3% |
|
